GeoVax announces the start of two new tests vaccines against HIV / AIDS human
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company based in Atlanta, announced the imminent launch of two new AIDS vaccine clinical (human) trials. These tests with the FDA were expected to begin in late 2007 and are the third and fourth in a series of four clinical studies to human safety and immune response to GeoVax HIV / AIDS vaccines correspond to evaluate.The immunodeficiency virus), vaccination of persons infected with DNA and MVA vaccines first with the virus. Since April 2006, the first of four human studies have evaluated a low dose (1/10th dose vaccine), the vaccination program. Preliminary results of this double-blind study demonstrated excellent vaccine safety and positive anti-HIV-1 in the immune response to the vaccine in 9 of 11
participants, where nine people received GeoVax HIV / AIDS and two have received placebo vaccine. All participants were normal healthy individuals.compiled for future publication. The second of four human studies, which began in September 2006, was designed to assess the results of a full dose administration GeoVax HIV / AIDS vaccines. New data shows excellent safety in this study at full dose. Other test results at Emory University by Dr. Harriet Robinson auxiliary was carried out, showed positive anti-HIV-1 in most vaccinated immune responses. The immune response to official figures will be later this year.
Excellent results of the first and second attempt by the four Test series has accelerated the start of human trials # 3 and # 4 allows. These studies began more
than a month earlier than originally planned. Due to the exceptionally good results, believes his team can GeoVaxs scientific vaccine the same way as in Test No. 3, the lower doses of the vaccine experiment, No. 4, which only managed GeoVaxs MVA vaccine.easier to vaccinate people, said Dr. Harriet Robinson, PhD., GeoVax Co-founder and Chairman of the Scientific Advisory Board. Don Hildebrand, GeoVax CEO / President / Co-founder, Flonase purchase
Pages: [1] 2 3